Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ARDT vs UHS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ARDT
Ardent Health Partners, LLC

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$1.41B
5Y Perf.-44.7%
UHS
Universal Health Services, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$10.68B
5Y Perf.-20.2%

ARDT vs UHS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ARDT logoARDT
UHS logoUHS
IndustryMedical - Care FacilitiesMedical - Care Facilities
Market Cap$1.41B$10.68B
Revenue (TTM)$6.43B$17.76B
Net Income (TTM)$134M$1.52B
Gross Margin60.5%67.6%
Operating Margin8.9%11.5%
Forward P/E8.7x7.3x
Total Debt$2.26B$5.51B
Cash & Equiv.$710M$138M

ARDT vs UHSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ARDT
UHS
StockJul 24May 26Return
Ardent Health Partn… (ARDT)10055.3-44.7%
Universal Health Se… (UHS)10079.8-20.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: ARDT vs UHS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UHS leads in 7 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
ARDT
Ardent Health Partners, LLC
The Income Pick

ARDT is the clearest fit if your priority is income & stability.

  • Dividend streak 1 yrs, beta 1.40
Best for: income & stability
UHS
Universal Health Services, Inc.
The Growth Play

UHS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 9.7%, EPS growth 37.3%, 3Y rev CAGR 9.0%
  • 30.8% 10Y total return vs ARDT's -38.5%
  • Lower volatility, beta 0.60, Low D/E 74.3%, current ratio 1.05x
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthUHS logoUHS9.7% revenue growth vs ARDT's 6.0%
ValueUHS logoUHSLower P/E (7.3x vs 8.7x)
Quality / MarginsUHS logoUHS8.6% margin vs ARDT's 2.1%
Stability / SafetyUHS logoUHSBeta 0.60 vs ARDT's 1.40, lower leverage
DividendsUHS logoUHS0.5% yield; 1-year raise streak; the other pay no meaningful dividend
Momentum (1Y)UHS logoUHS-8.2% vs ARDT's -30.5%
Efficiency (ROA)UHS logoUHS9.8% ROA vs ARDT's 2.6%, ROIC 12.3% vs 7.5%

ARDT vs UHS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ARDTArdent Health Partners, LLC
FY 2025
Reportable Segment
100.0%$6.3B
UHSUniversal Health Services, Inc.
FY 2025
Acute Care Hospital Services
57.2%$9.9B
Behavioral Health Services
42.8%$7.4B

ARDT vs UHS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUHSLAGGINGARDT

Income & Cash Flow (Last 12 Months)

UHS leads this category, winning 6 of 6 comparable metrics.

UHS is the larger business by revenue, generating $17.8B annually — 2.8x ARDT's $6.4B. UHS is the more profitable business, keeping 8.6% of every revenue dollar as net income compared to ARDT's 2.1%.

MetricARDT logoARDTArdent Health Par…UHS logoUHSUniversal Health …
RevenueTrailing 12 months$6.4B$17.8B
EBITDAEarnings before interest/tax$733M$2.7B
Net IncomeAfter-tax profit$134M$1.5B
Free Cash FlowCash after capex$214M$894M
Gross MarginGross profit ÷ Revenue+60.5%+67.6%
Operating MarginEBIT ÷ Revenue+8.9%+11.5%
Net MarginNet income ÷ Revenue+2.1%+8.6%
FCF MarginFCF ÷ Revenue+3.3%+5.0%
Rev. Growth (YoY)Latest quarter vs prior year+7.0%+9.6%
EPS Growth (YoY)Latest quarter vs prior year-3.4%+17.7%
UHS leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

Evenly matched — ARDT and UHS each lead in 3 of 6 comparable metrics.

At 7.4x trailing earnings, UHS trades at a 28% valuation discount to ARDT's 10.3x P/E. On an enterprise value basis, UHS's 6.1x EV/EBITDA is more attractive than ARDT's 6.2x.

MetricARDT logoARDTArdent Health Par…UHS logoUHSUniversal Health …
Market CapShares × price$1.4B$10.7B
Enterprise ValueMkt cap + debt − cash$3.0B$16.0B
Trailing P/EPrice ÷ TTM EPS10.29x7.38x
Forward P/EPrice ÷ next-FY EPS est.8.65x7.30x
PEG RatioP/E ÷ EPS growth rate0.46x
EV / EBITDAEnterprise value multiple6.17x6.14x
Price / SalesMarket cap ÷ Revenue0.22x0.61x
Price / BookPrice ÷ Book value/share0.83x1.48x
Price / FCFMarket cap ÷ FCF5.47x12.57x
Evenly matched — ARDT and UHS each lead in 3 of 6 comparable metrics.

Profitability & Efficiency

UHS leads this category, winning 6 of 8 comparable metrics.

UHS delivers a 20.7% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $8 for ARDT. UHS carries lower financial leverage with a 0.74x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARDT's 1.34x.

MetricARDT logoARDTArdent Health Par…UHS logoUHSUniversal Health …
ROE (TTM)Return on equity+8.0%+20.7%
ROA (TTM)Return on assets+2.6%+9.8%
ROICReturn on invested capital+7.5%+12.3%
ROCEReturn on capital employed+7.9%+16.0%
Piotroski ScoreFundamental quality 0–966
Debt / EquityFinancial leverage1.34x0.74x
Net DebtTotal debt minus cash$1.6B$5.4B
Cash & Equiv.Liquid assets$710M$138M
Total DebtShort + long-term debt$2.3B$5.5B
Interest CoverageEBIT ÷ Interest expense6.36x10.92x
UHS leads this category, winning 6 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

UHS leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in UHS five years ago would be worth $11,248 today (with dividends reinvested), compared to $6,152 for ARDT. Over the past 12 months, UHS leads with a -8.2% total return vs ARDT's -30.5%. The 3-year compound annual growth rate (CAGR) favors UHS at 6.5% vs ARDT's -15.0% — a key indicator of consistent wealth creation.

MetricARDT logoARDTArdent Health Par…UHS logoUHSUniversal Health …
YTD ReturnYear-to-date+14.4%-22.3%
1-Year ReturnPast 12 months-30.5%-8.2%
3-Year ReturnCumulative with dividends-38.5%+20.8%
5-Year ReturnCumulative with dividends-38.5%+12.5%
10-Year ReturnCumulative with dividends-38.5%+30.8%
CAGR (3Y)Annualised 3-year return-15.0%+6.5%
UHS leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

UHS leads this category, winning 2 of 2 comparable metrics.

UHS is the less volatile stock with a 0.60 beta — it tends to amplify market swings less than ARDT's 1.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UHS currently trades 69.2% from its 52-week high vs ARDT's 63.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricARDT logoARDTArdent Health Par…UHS logoUHSUniversal Health …
Beta (5Y)Sensitivity to S&P 5001.40x0.60x
52-Week HighHighest price in past year$15.48$246.33
52-Week LowLowest price in past year$8.07$152.33
% of 52W HighCurrent price vs 52-week peak+63.8%+69.2%
RSI (14)Momentum oscillator 0–10046.639.7
Avg Volume (50D)Average daily shares traded382K793K
UHS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates ARDT as "Buy" and UHS as "Hold". Consensus price targets imply 35.7% upside for UHS (target: $232) vs 34.9% for ARDT (target: $13). UHS is the only dividend payer here at 0.47% yield — a key consideration for income-focused portfolios.

MetricARDT logoARDTArdent Health Par…UHS logoUHSUniversal Health …
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$13.33$231.50
# AnalystsCovering analysts1243
Dividend YieldAnnual dividend ÷ price+0.5%
Dividend StreakConsecutive years of raises11
Dividend / ShareAnnual DPS$0.80
Buyback YieldShare repurchases ÷ mkt cap0.0%+9.1%
Insufficient data to determine a leader in this category.
Key Takeaway

UHS leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.

Best OverallUniversal Health Services, … (UHS)Leads 4 of 6 categories
Loading custom metrics...

ARDT vs UHS: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is ARDT or UHS a better buy right now?

For growth investors, Universal Health Services, Inc.

(UHS) is the stronger pick with 9. 7% revenue growth year-over-year, versus 6. 0% for Ardent Health Partners, LLC (ARDT). Universal Health Services, Inc. (UHS) offers the better valuation at 7. 4x trailing P/E (7. 3x forward), making it the more compelling value choice. Analysts rate Ardent Health Partners, LLC (ARDT) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ARDT or UHS?

On trailing P/E, Universal Health Services, Inc.

(UHS) is the cheapest at 7. 4x versus Ardent Health Partners, LLC at 10. 3x. On forward P/E, Universal Health Services, Inc. is actually cheaper at 7. 3x.

03

Which is the better long-term investment — ARDT or UHS?

Over the past 5 years, Universal Health Services, Inc.

(UHS) delivered a total return of +12. 5%, compared to -38. 5% for Ardent Health Partners, LLC (ARDT). Over 10 years, the gap is even starker: UHS returned +30. 8% versus ARDT's -38. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ARDT or UHS?

By beta (market sensitivity over 5 years), Universal Health Services, Inc.

(UHS) is the lower-risk stock at 0. 60β versus Ardent Health Partners, LLC's 1. 40β — meaning ARDT is approximately 132% more volatile than UHS relative to the S&P 500. On balance sheet safety, Universal Health Services, Inc. (UHS) carries a lower debt/equity ratio of 74% versus 134% for Ardent Health Partners, LLC — giving it more financial flexibility in a downturn.

05

Which is growing faster — ARDT or UHS?

By revenue growth (latest reported year), Universal Health Services, Inc.

(UHS) is pulling ahead at 9. 7% versus 6. 0% for Ardent Health Partners, LLC (ARDT). On earnings-per-share growth, the picture is similar: Universal Health Services, Inc. grew EPS 37. 3% year-over-year, compared to -39. 2% for Ardent Health Partners, LLC. Over a 3-year CAGR, UHS leads at 9. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ARDT or UHS?

Universal Health Services, Inc.

(UHS) is the more profitable company, earning 8. 6% net margin versus 2. 1% for Ardent Health Partners, LLC — meaning it keeps 8. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UHS leads at 11. 5% versus 5. 1% for ARDT. At the gross margin level — before operating expenses — ARDT leads at 97. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ARDT or UHS more undervalued right now?

On forward earnings alone, Universal Health Services, Inc.

(UHS) trades at 7. 3x forward P/E versus 8. 7x for Ardent Health Partners, LLC — 1. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UHS: 35. 7% to $231. 50.

08

Which pays a better dividend — ARDT or UHS?

In this comparison, UHS (0.

5% yield) pays a dividend. ARDT does not pay a meaningful dividend and should not be held primarily for income.

09

Is ARDT or UHS better for a retirement portfolio?

For long-horizon retirement investors, Universal Health Services, Inc.

(UHS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 60)). Both have compounded well over 10 years (UHS: +30. 8%, ARDT: -38. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ARDT and UHS?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ARDT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 36%
Run This Screen
Stocks Like

UHS

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ARDT and UHS on the metrics below

Revenue Growth>
%
(ARDT: 7.0% · UHS: 9.6%)
Net Margin>
%
(ARDT: 2.1% · UHS: 8.6%)
P/E Ratio<
x
(ARDT: 10.3x · UHS: 7.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.